English
Spanish
French
German
Italian
Portuguese
Russian
Chinese (Simplified)
Hindi
Japanese
WASHINGTON — President Trump announced the launch of a new website Tuesday giving Americans the chance to buy drugs directly from the government rather than going through insurance.
Trump, 79, also announced that Pfizer plans to lower its prices on some medications distributed in the US, predicting Americans will save “hundreds of millions of dollars a year.”
“I think it’s one of the biggest things that we’ll do. We’ll be reducing drug prices by 100% in some cases, 300% or more,” Trump told reporters on the South Lawn of the White House ahead of the announcement.
“Pfizer is committing to offer all of their prescription medications to Medicaid, and it will be at the most favored nation’s prices,” the president said moments later in the Oval Office. “It’s going to have a huge impact on bringing Medicaid costs down like nothing else.”
Most favored nation (MFN) prices are calculated by taking net consumer prices and comparing them against her wealthy countries.
The price then gets negotiated with the US market in mind.
Pfizer also agreed to provide some of their popular medications at discounted rates of between 50 and 100%, and all new medications announced will be offered at the most favored nation rate to the US, Trump said.
Among the medications available on TrumpRx at the reduced rate are Xeljanz for rheumatoid arthritis (40% discount), Zavzpret for migranes (50%), Eucrisa for dermatitis (80%), and Duavee for female osteoporosis (85%).
In addition, Pfizer will invest $70 billion in bringing manufacturing facilities back into the US, as well as research and development.
“It’s an historic day, because I think today we are turning the tide, and we are reversing an unfair situation,” Pfizer CEO Albert Bourla said in the Oval Office alongside Trump.
Medicare Director Chris Klomp said the site will provide consumers “direct access” and will also have MFN pricing and “at lower prices than currently available.”
“This is bypassing middlemen. It increases transparency. In many instances, prices are 80% lower than they are today,” Klomp said.
Trump lambasted foreign countries for “taking advantage” of the US on drug prices in his announcement and was heavily involved in getting the deal through, Health and Human Services Secretary Robert F. Kennedy Jr. stressed.
Trump “harangued and harassed us” to finish the deal, Kennedy said, adding that “at one point, [Centers for Medicare and Medicaid Services Administrator] Dr. [Mehmet] Oz told me, ‘I can’t take the president’s calls anymore,’” Kennedy said.
“President Trump is doing more to lower healthcare costs than anyone else in Washington, D.C.,” White House spokesman Kush Desai said in a statement.
“While Democrats are threatening to shut down the federal government to subsidize health care for illegal aliens, President Trump is leveraging the power of the federal government to drastically cut drug prices for everyday Americans. Democrats talked the talk for decades about drug prices, but only President Trump is actually walking the walk.”
The drug announcement comes one day before Trump’s deadline for pharmaceutical companies to move their manufacturing operations to the US — or face a 100% tariff.
“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump wrote on Truth Social last week.
Companies already building manufacturing sites in the US will not be subjected to the tariff.
The tariff will most likely impact smaller pharma companies who do not have facilities in the US, while larger ones may be spared.
Companies like Johnson & Johnson, Eli Lilly, Merck, AstraZeneca and Novo Nordisk already have manufacturing plants in the US.
